News & Media Library
EveryONE Medicines and Mendelian Partner to Transform UK Landscape for Rare Disease Diagnosis and Personalized Treatment
April 29, 2025
EveryONE Medicines Announces Appointment of Michelle L. Mellion, MD, as Chief Medical Officer
April 16, 2025
Developing Bespoke Antisense Oligonucleotides To Treat Rare Diseases – Life Science Connect
November 26, 2024
Biopharma Entrepreneurs Make Business Case for Personalized Genetic Medicines – BioSpace
August 7, 2024
EveryONE Medicines Appoints Kent Rogers as Chief Executive Officer and Josh Ofman, MD, MSHS, as Chairman of the Board - Business Wire
July 10, 2024
Start-up aims to make personalized medicines. Is it scalable? - Chemical & Engineering News
July 10, 2024
Building a Bridge Between Rare Disease Patients and the Technologies that Could Help Them – Inside Precision Medicine
June 4, 2024
EveryONE Medicines: Designing Drugs for Rare Diseases, One at a Time - Wall Street Journal
April 25, 2024